Navigation Links
High-dose Vorinostat effective at treating relapsed lymphomas
Date:2/4/2013

SEATTLE Patients whose aggressive lymphomas have relapsed or failed to respond to the current front-line chemotherapy regimen now have an effective second line of attack against their disease. Reporting the results of a first-of-its-kind phase 1 clinical trial to test the effectiveness of a new class of drugs to augment standard chemotherapy, a team led by Fred Hutchinson Cancer Research Center scientists found that giving patients high doses of Vorinostat (suberoylanilide hydroxamic acid) in combination with another round of commonly used second-line drugs resulted in a 70 percent response rate, including several patients whose lymphoma cells disappeared entirely.

According to Ajay Gopal, M.D., associate member of the Fred Hutch Clinical Research Division and corresponding author of the paper, published online in the British Journal of Haematology, the study results open the way to potentially solve the dilemma of how to effectively treat patients when modern cancer drugs fail after the first try. And, he said, it sets the stage for using a new class of drugs called histone-deacetylase inhibitors (HDAC), of which Vorinostat is one, to sensitize tumor cells to the cancer-killing effects of chemotherapy.

Patients treated in the trial had several types of lymphoma, however the best responses were seen in those who had Hodgkin and diffuse large B-cell lymphomas, two of the most aggressive types that typically require a stem cell transplant to cure if they are not cured after the first line of treatment. Knocking back the cancer raises the likelihood for a successful transplant.

"The better the response, the better the outcome will be when patients proceed to a stem cell transplant designed to cure them of their disease," said Elizabeth Budde, M.D., Ph.D., a research associate in the Fred Hutch Clinical Research Division and first author of the study.

The researchers noted that while the current front-line chemotherapy drugs are the most eff
'/>"/>

Contact: Dean Forbes
dforbes@fhcrc.org
206-667-2896
Fred Hutchinson Cancer Research Center
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Controlling spine metastases with tumor separation surgery and high-dose stereotactic radiosurgery
2. Announcement: New Website for Effective Environmental Services Just Went Live
3. Family practice offers genetic tests to predict effective psychiatric meds, a CAMH study
4. Constipation Treatments Not Equally Effective: Review
5. Emotional stress reduces effectiveness of prostate cancer therapies in animal model
6. Candida Treatment
7. How “Yeast Infection No More” Can Help People Treat Candida Effectively - Health Reviews
8. Social Scientists call for more effective teaching in Higher Education
9. Chemo Pills Effective, But Patients May Skip Doses
10. Gastric banding an effective long-term solution to obesity
11. As colorectal cancer gets more aggressive, treatment with grape seed extract is even more effective
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/31/2015)... CA (PRWEB) March 31, 2015 Dr. Poneh ... now offer patients valuable savings through new Spring specials. Dr. ... off the holiday celebration this year by taking advantage of ... , "Spring brings together friends and loved ones that ... media. We are pleased to offer solutions for a great ...
(Date:3/31/2015)... 31, 2015 A' Design Award and ... Bruker EVOQ by Daniel Dion has been announced as ... Scientific Instruments, Medical Devices and Research Equipment Design ... the creative mind behind the award winning Medical Product ... developed under the direction of Dr. Rohan Thakur and ...
(Date:3/31/2015)... 2015 According to a recent YouGov/Huffington ... Americans interviewed supported detox and abstinence, while only 19% ... methadone.(1) Although many within the healthcare community advocate for ... suggest that most Americans concur with Novus Medical ... drug use is a better approach than prescribing other ...
(Date:3/31/2015)... March 31, 2015 A team of ... polyphenol with anti-cancer properties, into mesothelioma cancer cells. Surviving ... research on its website. Click here to read ... the yellow color to the spice turmeric, has limited ... bioavailability. Biomaterials experts at Università di Napoli Federico II ...
(Date:3/31/2015)... TN (PRWEB) March 31, 2015 Dr. ... welcomes warmer temperatures and sunshine; however, it's important to be ... eye damage. Experts say more than 90 percent ... few precautions and wearing safety glasses. Dr. Shofner shares five ... this season. , 1) Yard Work. While using a lawn ...
Breaking Medicine News(10 mins):Health News:West Hollywood Cosmetic Dentist, Dr. Poneh Ghasri, is Now Offering Various Special Offers Just in Time for Spring 2Health News:Daniel Dion wins Golden in A' Medical Product Design Awards 2Health News:Novus Medical Detox Center Highlights Survey Findings: More Americans Support Detox and Rehab Over Methadone as Treatment for Heroin Addiction 2Health News:Novus Medical Detox Center Highlights Survey Findings: More Americans Support Detox and Rehab Over Methadone as Treatment for Heroin Addiction 3Health News:Novus Medical Detox Center Highlights Survey Findings: More Americans Support Detox and Rehab Over Methadone as Treatment for Heroin Addiction 4Health News:New Research Reveals Novel Delivery Method for Potential Mesothelioma Treatment, According to Surviving Mesothelioma 2Health News:Popular Springtime Activities That Could Cause Irreversible Eye Damage by Renowned Eye Surgeon Dr. Stewart Shofner 2Health News:Popular Springtime Activities That Could Cause Irreversible Eye Damage by Renowned Eye Surgeon Dr. Stewart Shofner 3Health News:Popular Springtime Activities That Could Cause Irreversible Eye Damage by Renowned Eye Surgeon Dr. Stewart Shofner 4
... cholesterol and high blood pressure in people who,ve had a ... attack, according to a study to be presented as part ... Neurology,s 61st Annual Meeting in Seattle, April 25 - May ... LDL cholesterol, low HDL cholesterol, high triglycerides, and high blood ...
... -- Traumatic brain injury (TBI), a complex ... among Veterans and has been called one of the ... TBI is wide-ranging. Among its goals: shedding light on ... screening and diagnosis; developing drugs to treat brain injury ...
... April 30, 2009) A unique mother-daughter study that ... shows that percent of breast water could be linked to ... , The findings, published online today in Lancet Oncology ... more about breast density, an inheritable characteristic known to be ...
... of a novel therapy that uses magnetic pulses to ... a promising alternative to medication. , The therapy is ... were presented today (April 29, 2009) during the annual ... , In a previous randomized controlled clinical study ...
... Washing Hands, Recognizing Symptoms Key to Prevent Spread , ... attention to symptoms of illness are just some of ... the risk from the swine flu (H1N1) outbreak, the ... )"This is a serious situation that has ...
... ... 9:00 a.m. EDT, ... 1-800-814-4860, ... invites analysts and investors to participate in a briefing on Wednesday, May 6, 2009, with ...
Cached Medicine News:Health News:Controlling Cholesterol, Blood Pressure Adds Up to Prevent Stroke 2Health News:Video: Turning Hope Into Reality - Traumatic Brain Injury Research at the VA 2Health News:Mother-daughter breast density study points way to earlier cancer risk assessment 2Health News:New therapy based on magnetic stimulation shows promise for non-drug treatment for migraine 2Health News:Red Cross Urges Families and Communities to Prepare During Swine Flu Outbreak 2Health News:Red Cross Urges Families and Communities to Prepare During Swine Flu Outbreak 3Health News:Conference Call Advisory - NUCRYST Pharmaceuticals Corp. Conference Call to Discuss 2009 First Quarter Results 2
(Date:3/30/2015)... , March 30, 2015 ... My Diabetes Emergency Plan at the 2015 @NatHurricaneCon ... to be prepared to manage your #diabetes before emergencies ... (ACE) – the charitable, educational and scientific arm of ... joined forces with Lilly Diabetes to share the ...
(Date:3/30/2015)... 30, 2015  Check-Cap Ltd. (NASDAQ: CHEK ), ... development of a preparation-free ingestible imaging capsule that utilizes ... today that its CEO, Guy Neev , will ring ... day.  Neev and Check-Cap will participate in the closing ... public offering and simultaneous private placement which raised a ...
(Date:3/30/2015)... and ORANGEBURG, N.Y., March 30, 2015  Uroplasty, ... VSCI ) shareholders have voted at the ... to approve the previously announced agreement and plan ... "We are pleased with the outcome of today,s ... both shareholder groups for approving the merger agreement," ...
Breaking Medicine Technology:Preparation Is Personal for Those with Chronic Illnesses 2Preparation Is Personal for Those with Chronic Illnesses 3Preparation Is Personal for Those with Chronic Illnesses 4Check-Cap to Celebrate Initial Public Offering with NASDAQ Closing Bell Ceremony on March 31, 2015 2Check-Cap to Celebrate Initial Public Offering with NASDAQ Closing Bell Ceremony on March 31, 2015 3Uroplasty and Vision-Sciences Shareholders Approve Merger Agreement 2Uroplasty and Vision-Sciences Shareholders Approve Merger Agreement 3Uroplasty and Vision-Sciences Shareholders Approve Merger Agreement 4
... , EAST HANOVER, N.J., Oct. 12 Novartis Pharma AG ... rights to Fanapt(TM) (iloperidone), a new oral medication ... (FDA) for the acute treatment of adults with schizophrenia. Novartis ... early 2010. , As part of the agreement with ...
... 12 Hospira, Inc. (NYSE: HSP ), a leading ... the company will present at the Credit Suisse 18th Annual ... , The presentation is scheduled to begin at 8:00 a.m. ... will be available to all interested parties through a live ...
Cached Medicine Technology:Novartis Enters Into Agreement for Exclusive US and Canadian Rights to Fanapt(TM), an FDA-Approved Oral Therapy for Schizophrenia 2Novartis Enters Into Agreement for Exclusive US and Canadian Rights to Fanapt(TM), an FDA-Approved Oral Therapy for Schizophrenia 3Novartis Enters Into Agreement for Exclusive US and Canadian Rights to Fanapt(TM), an FDA-Approved Oral Therapy for Schizophrenia 4Novartis Enters Into Agreement for Exclusive US and Canadian Rights to Fanapt(TM), an FDA-Approved Oral Therapy for Schizophrenia 5Novartis Enters Into Agreement for Exclusive US and Canadian Rights to Fanapt(TM), an FDA-Approved Oral Therapy for Schizophrenia 6Novartis Enters Into Agreement for Exclusive US and Canadian Rights to Fanapt(TM), an FDA-Approved Oral Therapy for Schizophrenia 7Novartis Enters Into Agreement for Exclusive US and Canadian Rights to Fanapt(TM), an FDA-Approved Oral Therapy for Schizophrenia 8
... Injectable was designed to provide the surgeon with ... of surgical complications during cataract and retinal surgery. ... small and medium sized pupils which allows expansion ... iris sphincter during surgery, and allows the pupil ...
... Laminar Flow Unit is a flexible, total solution. ... to operating theaters since 1983. A major part ... and extensive experience from all the different areas ... product , ,Kojair Tech Oy is a comprehensive ...
Provides stable positioning of the knee during surgery....
BRAT 2 Autologous Blood Recovery System gives performance, speed, versatility, and quality processing. , ,The BRAT 2 is now available with on-board Vacuum, programmability, plasma sequestration, Data...
Medicine Products: